Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors

Multiple myeloma (MM) is still a fatal plasma cell cancer. Novel compounds are currently clinically tested as a single agent in relapsing patients, but in best cases with partial response of a fraction of patients, emphasising the need to design tools predicting drug efficacy. Histone deacetylase in...

Full description

Saved in:
Bibliographic Details
Main Authors: Moreaux, Jérôme (Author) , Reme, T. (Author) , Leonard, W. (Author) , Veyrune, J.-L. (Author) , Requirand, G. (Author) , Goldschmidt, Hartmut (Author) , Hose, Dirk (Author) , Klein, B. (Author)
Format: Article (Journal)
Language:English
Published: 18 July 2013
In: British journal of cancer
Year: 2013, Volume: 109, Issue: 3, Pages: 676-685
ISSN:1532-1827
DOI:10.1038/bjc.2013.392
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/bjc.2013.392
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/bjc2013392
Get full text
Author Notes:J. Moreaux, T. Reme, W. Leonard, J.-L. Veyrune, G. Requirand, H. Goldschmidt, D. Hose and B. Klein

MARC

LEADER 00000caa a2200000 c 4500
001 1759917249
003 DE-627
005 20230427063246.0
007 cr uuu---uuuuu
008 210607s2013 xx |||||o 00| ||eng c
024 7 |a 10.1038/bjc.2013.392  |2 doi 
035 |a (DE-627)1759917249 
035 |a (DE-599)KXP1759917249 
035 |a (OCoLC)1341415373 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Moreaux, Jérôme  |e VerfasserIn  |0 (DE-588)1158626851  |0 (DE-627)1020610077  |0 (DE-576)504256734  |4 aut 
245 1 0 |a Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors  |c J. Moreaux, T. Reme, W. Leonard, J.-L. Veyrune, G. Requirand, H. Goldschmidt, D. Hose and B. Klein 
264 1 |c 18 July 2013 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 07.06.2021 
520 |a Multiple myeloma (MM) is still a fatal plasma cell cancer. Novel compounds are currently clinically tested as a single agent in relapsing patients, but in best cases with partial response of a fraction of patients, emphasising the need to design tools predicting drug efficacy. Histone deacetylase inhibitors (HDACi) are anticancer agents targeting epigenetic regulation of gene expression and are in clinical development in MM. 
700 1 |a Reme, T.  |e VerfasserIn  |4 aut 
700 1 |a Leonard, W.  |e VerfasserIn  |4 aut 
700 1 |a Veyrune, J.-L.  |e VerfasserIn  |4 aut 
700 1 |a Requirand, G.  |e VerfasserIn  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
700 1 |a Hose, Dirk  |d 1969-  |e VerfasserIn  |0 (DE-588)139824995  |0 (DE-627)613790308  |0 (DE-576)313431698  |4 aut 
700 1 |a Klein, B.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t British journal of cancer  |d Edinburgh : Nature Publ. Group, 1947  |g 109(2013), 3, Seite 676-685  |h Online-Ressource  |w (DE-627)320420094  |w (DE-600)2002452-6  |w (DE-576)103746854  |x 1532-1827  |7 nnas  |a Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors 
773 1 8 |g volume:109  |g year:2013  |g number:3  |g pages:676-685  |g extent:10  |a Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors 
856 4 0 |u https://doi.org/10.1038/bjc.2013.392  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/bjc2013392  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210607 
993 |a Article 
994 |a 2013 
998 |g 139824995  |a Hose, Dirk  |m 139824995:Hose, Dirk  |d 910000  |d 910100  |e 910000PH139824995  |e 910100PH139824995  |k 0/910000/  |k 1/910000/910100/  |p 7 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |e 910000PG102258023X  |e 910100PG102258023X  |k 0/910000/  |k 1/910000/910100/  |p 6 
999 |a KXP-PPN1759917249  |e 3935124910 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"18 July 2013"}],"note":["Gesehen am 07.06.2021"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors","title":"Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors"}],"person":[{"given":"Jérôme","role":"aut","family":"Moreaux","display":"Moreaux, Jérôme"},{"given":"T.","role":"aut","display":"Reme, T.","family":"Reme"},{"role":"aut","given":"W.","display":"Leonard, W.","family":"Leonard"},{"given":"J.-L.","role":"aut","family":"Veyrune","display":"Veyrune, J.-L."},{"given":"G.","role":"aut","family":"Requirand","display":"Requirand, G."},{"given":"Hartmut","role":"aut","family":"Goldschmidt","display":"Goldschmidt, Hartmut"},{"role":"aut","given":"Dirk","family":"Hose","display":"Hose, Dirk"},{"role":"aut","given":"B.","display":"Klein, B.","family":"Klein"}],"id":{"doi":["10.1038/bjc.2013.392"],"eki":["1759917249"]},"relHost":[{"recId":"320420094","pubHistory":["Volume 1, issue 1 (1 March 1947)-"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1532-1827"],"eki":["320420094"],"zdb":["2002452-6"]},"disp":"Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitorsBritish journal of cancer","language":["eng"],"part":{"issue":"3","pages":"676-685","text":"109(2013), 3, Seite 676-685","year":"2013","volume":"109","extent":"10"},"origin":[{"dateIssuedKey":"1947","publisher":"Nature Publ. Group ; Churchill Livingstone","dateIssuedDisp":"1947-","publisherPlace":"Edinburgh ; Edinburgh"}],"note":["Gesehen am 27.10.25"],"type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"BJC"}],"title":[{"title":"British journal of cancer","subtitle":"BJC","title_sort":"British journal of cancer"}]}],"recId":"1759917249","physDesc":[{"extent":"10 S."}],"name":{"displayForm":["J. Moreaux, T. Reme, W. Leonard, J.-L. Veyrune, G. Requirand, H. Goldschmidt, D. Hose and B. Klein"]}} 
SRT |a MOREAUXJERGENEEXPRES1820